Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers

British Journal of Cancer

Volumn 113, Issue 7, 2015, Pages 1035-1045

  Exner, Ruth ^a   Pulverer, Walter ^b   Diem, Martina ^a   Spaller, Lisa ^a   Woltering, Laura ^a   Schreiber, Martin ^c   Wolf, Brigitte ^a   Sonntagbauer, Markus ^b   Schröder, Fabian ^b   Stift, Judith ^a   Wrba, Fritz ^a   Bergmann, Michael ^a   Weinhäusel, Andreas ^b   Egger, Gerda ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

^c UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

DNA methylation; CpG methylator phenotype; CIMP; rectal cancer; epigenetic biomarker

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; P16 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER THERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA METHYLATION; DNA MICROARRAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROFLUIDIC ANALYSIS; OVERALL SURVIVAL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECTUM CARCINOMA; SENSITIVITY AND SPECIFICITY; GENETICS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; RECTUM TUMOR; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84942982429     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.303     Document Type: Article

References (55)

1. Bae JM, Kim JH, Cho NY, Kim TY, Kang GH (2013) Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer 109(4): 1004-1012
2. Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, Roignot P, Rat P, Bouvier AM, Laurent-Puig P, Faivre J, Chapusot C, Piard F (2008) Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 68(20): 8541-8546
3. Benard A, van de Velde CJ, Lessard L, Putter H, Takeshima L, Kuppen PJ, Hoon DS (2013) Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. Br J Cancer 109(12): 3073-3083
4. Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF (2007) Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys 68(5): 1455-1461
5. Campan M, Weisenberger DJ, Trinh B, Laird PW (2009) MethyLight. Methods Mol Biol 507: 325-337
6. Cho HJ, Kim SY, Kim KH, Kang WK, Kim JI, Oh ST, Kim JS, An CH (2009) The combination effect of sodium butyrate and 5-Aza-20-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines. World J Surg Oncol 7: 49
7. Dahlin AM, Palmqvist R, Henriksson ML, Jacobsson M, Eklof V, Rutegard J, Oberg A, Van Guelpen BR (2010) The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res 16(6): 1845-1855
8. de Maat MF, van de Velde CJ, Benard A, Putter H, Morreau H, van Krieken JH, Meershoek Klein-Kranenbarg E, de Graaf EJ, Tollenaar RA, Hoon DS (2010) Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer. Clin Cancer Res 16(10): 2811-2818
9. de Maat MF, van de Velde CJ, van der Werff MP, Putter H, Umetani N, Klein-Kranenbarg EM, Turner RR, van Krieken JH, Bilchik A, Tollenaar RA, Hoon DS (2008) Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence. J Clin Oncol 26(14): 2327-2335
10. De Schutter H, Nuyts S (2009) Radiosensitizing potential of epigenetic anticancer drugs. Anticancer Agents Med Chem 9(1): 99-108
11. Derks S, Bosch LJ, Niessen HE, Moerkerk PT, van den Bosch SM, Carvalho B, Mongera S, Voncken JW, Meijer GA, de Bruine AP, Herman JG, van Engeland M (2009) Promoter CpG island hypermethylation-And H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Carcinogenesis 30(6): 1041-1048
12. Draht MX, Riedl RR, Niessen H, Carvalho B, Meijer GA, Herman JG, van Engeland M, Melotte V, Smits KM (2012) Promoter CpG island methylation markers in colorectal cancer: the road ahead. Epigenomics 4(2): 179-194
13. Du C, Zhao J, Xue W, Dou F, Gu J (2013) Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy. Histopathology 62(5): 723-730
14. Dudoit S, Fridlyand J, Speed TP (2002) Comparison of discrimination methods for the classification of tumors using gene expression data. J Am Stat Assoc 97(457): 77-87
15. Elliott GO, Johnson IT, Scarll J, Dainty J, Williams EA, Garg D, Coupe A, Bradburn DM, Mathers JC, Belshaw NJ (2013) Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection. Int J Colorectal Dis 28(1): 35-42
16. Glockner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruine AP, Smits KM, Khalid-de Bakker CA, Jonkers DM, Stockbrugger RW, Meijer GA, Oort FA, Iacobuzio-Donahue C, Bierau K, Herman JG, Baylin SB, Van Engeland M, Schuebel KE, Ahuja N (2009) Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 69(11): 4691-4699
17. Halvorsen AR, Helland A, Fleischer T, Haug KM, Grenaker Alnaes GI, Nebdal D, Syljuasen RG, Touleimat N, Busato F, Tost J, Saetersdal AB, Borresen-Dale AL, Kristensen V, Edvardsen H (2014) Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy. Int J Cancer 135(9): 2085-2095
18. Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y (2011) Detection of TFPI2 methylation in the serum of colorectal cancer patients. Cancer Lett 311(1): 96-100
19. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22(2): 271-282
20. Hofstetter B, Niemierko A, Forrer C, Benhattar J, Albertini V, Pruschy M, Bosman FT, Catapano CV, Ciernik IF (2010) Impact of genomic methylation on radiation sensitivity of colorectal carcinoma. Int J Radiat Oncol Biol Phys 76(5): 1512-1519
21. Iacopetta B (2002) Are there two sides to colorectal cancer? Int J Cancer 101(5): 403-408
22. Jee CD, Kim MA, Jung EJ, Kim J, Kim WH (2009) Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma. Eur J Cancer 45(7): 1282-1293
23. Jendrossek V (2013) Targeting apoptosis pathways by Celecoxib in cancer. Cancer Lett 332(2): 313-324
24. Jo P, Jung K, Grade M, Conradi LC, Wolff HA, Kitz J, Becker H, Ruschoff J, Hartmann A, Beissbarth T, Muller-Dornieden A, Ghadimi M, Schneider-Stock R, Gaedcke J (2012) CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer. Surgery 151(4): 564-570
25. Kim JG, Park MT, Heo K, Yang KM, Yi JM (2013) Epigenetics meets radiation biology as a new approach in cancer treatment. Int J Mol Sci 14(7): 15059-15073
26. Kohonen-Corish MR, Tseung J, Chan C, Currey N, Dent OF, Clarke S, Bokey L, Chapuis PH (2014) KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. Int J Cancer 134(12): 2820-2828
27. Kuhmann C, Weichenhan D, Rehli M, Plass C, Schmezer P, Popanda O (2011) DNA methylation changes in cells regrowing after fractioned ionizing radiation. Radiother Oncol 101(1): 116-121
28. Lange CP, Campan M, Hinoue T, Schmitz RF, van der Meulen-de Jong AE, Slingerland H, Kok PJ, van Dijk CM, Weisenberger DJ, Shen H, Tollenaar RA, Laird PW (2012) Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS One 7(11): e50266
29. Lange CP, Laird PW (2013) Clinical applications of DNA methylation biomarkers in colorectal cancer. Epigenomics 5(2): 105-108
30. Lee SM, Park JY, Kim DS (2012) Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer. Mol Cells 34(2): 171-176
31. Leong KJ, Wei W, Tannahill LA, Caldwell GM, Jones CE, Morton DG, Matthews GM, Bach SP (2011) Methylation profiling of rectal cancer identifies novel markers of early-stage disease. Br J Surg 98(5): 724-734
32. Liang G, Robertson KD, Talmadge C, Sumegi J, Jones PA (2000) The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Res 60(17): 4907-4912
33. Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K, Yeo CJ, Kalloo A, Hruban R, Goggins M (2006) DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 66(2): 1208-1217
34. Mikeska T, Bock C, Do H, Dobrovic A (2012) DNA methylation biomarkers in cancer: progress towards clinical implementation. Expert Rev Mol Diagn 12(5): 473-487
35. Monteiro-Reis S, Leca L, Almeida M, Antunes L, Monteiro P, Dias PC, Morais A, Oliveira J, Henrique R, Jeronimo C (2013) Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation. Eur J Cancer 50(1): 226-233
36. Network CGA (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407): 330-337
37. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS (2006) CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8(5): 582-588
38. Pulverer W, Wielscher M, Panzer-Grumayer R, Plessl T, Kriegner A, Vierlinger K, Weinhausel A (2012) The stem cell signature of CHH/CHG methylation is not present in 271 cancer associated 50UTR gene regions. Biochimie 94(11): 2345-2352
39. Radmacher MD, McShane LM, Simon R (2002) A paradigm for class prediction using gene expression profiles. J Comput Biol 9(3): 505-511
40. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, Lander ES, Golub TR (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98(26): 15149-15154
41. Ribarska T, Ingenwerth M, Goering W, Engers R, Schulz WA (2010) Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma. Cancer Genomics Proteomics 7(2): 51-60
42. Samowitz WS, Curtin K, Wolff RK, Tripp SR, Caan BJ, Slattery ML (2009) Microsatellite instability and survival in rectal cancer. Cancer Causes Control 20(9): 1763-1768
43. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X, Ahmed S, Konishi K, Hamilton SR, Issa JP (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 104(47): 18654-18659
44. Shin JS, Tut TG, Yang T, Lee CS (2013) Radiotherapy response in microsatellite instability related rectal cancer. Korean J Pathol 47(1): 1-8
45. Sova P, Feng Q, Geiss G, Wood T, Strauss R, Rudolf V, Lieber A, Kiviat N (2006) Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 15(1): 114-123
46. Sun W, Sun Y, Zhu M, Wang Z, Zhang H, Xin Y, Jiang G, Guo X, Zhang Z, Liu Y (2013) The role of plasma cell-free DNA detection in predicting preoperative chemoradiotherapy response in rectal cancer patients. Oncol Rep 31(3): 1466-1472
47. Tanaka K, Oshimura M, Kikuchi R, Seki M, Hayashi T, Miyaki M (1991) Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 349(6307): 340-342
48. Team RDC (2009) A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria
49. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96(15): 8681-8686
50. Toyota M, Shen L, Ohe-Toyota M, Hamilton SR, Sinicrope FA, Issa JP (2000) Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. Cancer Res 60(15): 4044-4048
51. Weinhäusel A, Pulverer W (2013) DNA methylation biomarkers for identification of colorectal cancer. European Patent Application EP2886659.4. Available from http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&II=1&ND=3&adjacent=true&locale=en-EP&FT=D&date=20150625&CC=WO&NR=2015091979A2&KC=A2
52. Weinhäusel A, Pichler R, Noehammer C (2009) Methylation Assay. European Patent Application EP 09450020.4. Available from: http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide. espacenet.com&II=4&ND=3&adjacent=true&locale=en-EP&FT=D&date=20111124&CC=US&NR=2011287968A1&KC=A1
53. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38(7): 787-793
54. Yagi K, Akagi K, Hayashi H, Nagae G, Tsuji S, Isagawa T, Midorikawa Y, Nishimura Y, Sakamoto H, Seto Y, Aburatani H, Kaneda A (2010) Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res 16(1): 21-33
55. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61(6): 847-854